Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Supiot

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 23, 2017
Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30years of life: A French multicentre cohort studyC Demoor-Goldschmidt, S Supiot, O Oberlin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2023
Limited applicability and implementation of the international oncology treatments guidelines in low- and middle-income countries, an example from the Mediterranean area bordersY Belkacemi, M-C Biston, N Benchekroun, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 23, 2022
[Clinical research in radiation oncology: how to move from the laboratory to the patient?]V Potiron, G Delpon, L Ollivier, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2021
Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancerL Duvergé, P-Y Bondiau, L Claude, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]I Latorzeff, P Sargos, G Créhange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 3, 2023
[Understanding/acceptance of radiotherapy: An ethical dilemma resolved by an ethics of care]R de Crevoisier, J Leseur, C Bouvet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 10, 2018
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendationsJ Langrand-Escure, R de Crevoisier, C Llagostera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancerI Latorzeff, A Camps-Maléa, S Supiot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology groupY Belkacemi, I Latorzeff, A Hasbini, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 28, 2023
[The morbidity and mortality review meetings in radiotherapy departments: Procedure, implementation and prospects of the "Proust" French national project]Y Belkacemi, K Debbi, C Besnard, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 23, 2017
Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30years of life: A French multicentre cohort studyC Demoor-Goldschmidt, S Supiot, O Oberlin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2023
Limited applicability and implementation of the international oncology treatments guidelines in low- and middle-income countries, an example from the Mediterranean area bordersY Belkacemi, M-C Biston, N Benchekroun, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 23, 2022
[Clinical research in radiation oncology: how to move from the laboratory to the patient?]V Potiron, G Delpon, L Ollivier, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2021
Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancerL Duvergé, P-Y Bondiau, L Claude, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]I Latorzeff, P Sargos, G Créhange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 3, 2023
[Understanding/acceptance of radiotherapy: An ethical dilemma resolved by an ethics of care]R de Crevoisier, J Leseur, C Bouvet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 10, 2018
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendationsJ Langrand-Escure, R de Crevoisier, C Llagostera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancerI Latorzeff, A Camps-Maléa, S Supiot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology groupY Belkacemi, I Latorzeff, A Hasbini, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 28, 2023
[The morbidity and mortality review meetings in radiotherapy departments: Procedure, implementation and prospects of the "Proust" French national project]Y Belkacemi, K Debbi, C Besnard, et al.
Pageof 8